Prostate cancer is the most frequently diagnosed cancer and is one of the leading causes of male cancer death in the world. Recently, in the course of our screening for a novel anticancer compound, we synthesized carbocyclic analogs of pyrrolo[2,3-d] pyrimidine nucleoside; compounds 5, and 6. In the current study, we report the effects of compound 5 on pleiotropic induction of cell death via up-regulation of AR-associated p21(Cip1) protein in prostate cancer cells with different androgen responsiveness, such as LNCaP (androgen-dependent and -sensitive), LNCaPC4-2 (androgen-independent and -sensitive; androgen-refractory), and DU145 (androgen-independent and -insensitive) cells. The treatment of LNCaP cells with 6 mu M compound 5 for 24 h ...
This study was aimed to evaluate detailed mechanisms on the apoptotic induction of benzyldihydroxyoc...
The use of chemotherapy in the treatment of cancer has stimulated the demand for better chemotherape...
Background: Combining different clinical agents to target multiple pathways in prostate cancer cells...
Prostate cancer is the most frequently diagnosed cancer and is one of the leading causes of male can...
Prostate cancer is the most frequently diagnosed cancer and is one of the leading causes of male can...
Prostate cancer is the most frequently diagnosed cancer and is one of the leading causes of male can...
Background: Previously, we synthesized a new carbocyclic analog of pyrrolo[2,3-d]pyrimidine nucleosi...
Background: Previously, we synthesized a new carbocyclic analog of pyrrolo[2,3-d]pyrimidine nucleosi...
Background: Previously, we synthesized a new carbocyclic analog of pyrrolo[2,3-d]pyrimidine nucleosi...
Background: Pyrrolo[2,3-d]pyrimidines have been recently reported to have anticancer activities thro...
SRJ23 (3, 19-(3-chloro-4-fluorobenzylidene andrographolide), a new semisynthetic derivative of andro...
Purpose 3,19-(3-Chloro-4-fluorobenzylidene)andrographolide (SRJ23), a new semisynthetic derivative ...
This study was aimed to evaluate detailed mechanisms on the apoptotic induction of benzyldihydroxyoc...
SummaryThe goal of our work was the design of DNA-damaging agents that disrupt both DNA repair and s...
This study was aimed to evaluate detailed mechanisms on the apoptotic induction of benzyldihydroxyoc...
This study was aimed to evaluate detailed mechanisms on the apoptotic induction of benzyldihydroxyoc...
The use of chemotherapy in the treatment of cancer has stimulated the demand for better chemotherape...
Background: Combining different clinical agents to target multiple pathways in prostate cancer cells...
Prostate cancer is the most frequently diagnosed cancer and is one of the leading causes of male can...
Prostate cancer is the most frequently diagnosed cancer and is one of the leading causes of male can...
Prostate cancer is the most frequently diagnosed cancer and is one of the leading causes of male can...
Background: Previously, we synthesized a new carbocyclic analog of pyrrolo[2,3-d]pyrimidine nucleosi...
Background: Previously, we synthesized a new carbocyclic analog of pyrrolo[2,3-d]pyrimidine nucleosi...
Background: Previously, we synthesized a new carbocyclic analog of pyrrolo[2,3-d]pyrimidine nucleosi...
Background: Pyrrolo[2,3-d]pyrimidines have been recently reported to have anticancer activities thro...
SRJ23 (3, 19-(3-chloro-4-fluorobenzylidene andrographolide), a new semisynthetic derivative of andro...
Purpose 3,19-(3-Chloro-4-fluorobenzylidene)andrographolide (SRJ23), a new semisynthetic derivative ...
This study was aimed to evaluate detailed mechanisms on the apoptotic induction of benzyldihydroxyoc...
SummaryThe goal of our work was the design of DNA-damaging agents that disrupt both DNA repair and s...
This study was aimed to evaluate detailed mechanisms on the apoptotic induction of benzyldihydroxyoc...
This study was aimed to evaluate detailed mechanisms on the apoptotic induction of benzyldihydroxyoc...
The use of chemotherapy in the treatment of cancer has stimulated the demand for better chemotherape...
Background: Combining different clinical agents to target multiple pathways in prostate cancer cells...